Coronary Stents Market (By Type: Bare Metal Stents, Drug Eluting Stent, Bio-absorbable stent; By Application: Angina, Myocardial Infarction) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2025

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 162

The global coronary stents market size is expected to worth around US$ 16.88 billion by 2025, and market is registering growth at 7% from 2018 to 2025.


The stent is a small elastic tube like mesh which is made up of materials such as cobalt alloy or stainless steel. Stents implantation is on small balloons and opened inside the artery to give support to the vessel wall and reinstate blood flow. Stenting does not involve any major incision as compared to coronary artery bypass; hence, patients are more comfortable with stents which is driving the market of coronary stents.. A coronary stents is used in a procedure called percutaneous coronary intervention (PCI). According to recent studies, coronary stents are used in more than 90% of PCI procedures. Stents are mainly used to reduce angina (chest pain) and have been shown to improve durability and decrease undesirable events in an acute myocardial infarction. The treatment for coronary heart disease includes balloon angioplasty, pharmaceuticals, and stenting of coronary artery bypass grafting. Coronary stents also pose lower complications and health risks to the patients post surgery and shown better recovery compared to coronary bypass surgery.

Market Dynamics

The key factors driving the growth of coronary stents market is the alarming rise in the prevalence of cardiovascular diseases globally According to American Heart Association (AHA), cardiovascular diseases claim more lives than cancer and chronic lower respiratory diseases combined each year. Coronary heart disease is the leading cause of mortality in the U.S. attributable to cardiovascular diseases followed by stroke, heart failure, hypertension and other diseases. Other factor driving the market include developing health infrastructure, lifestyle disease, increasing geriatric population, profound increase in healthcare spending and healthcare coverage, subsequent growth in the number of percutaneous coronary intervention (PCI) procedures, advanced medical technologies and procedure, full-fledged demographic shift toward the aging of society and the development of information and communication technologies (ICT). Growing funding and investment by government for the research and development of efficient and effective stents will soar the demand for coronary stents market during the forecast period. Favorable reimbursement policies have shown to increase the adoption of coronary stents in countries such as U.S., Canada, India and U.K. For instance, the government in India subsidized the prices of drug eluting and bare metal stents in India to drive the adoption of stents in the country.

However, there are few complications post implementation of stents such as blood clots and infections in the stent sites. Blood clots and blockage are the most common which can be prevented by medicines such as aspirin and anti-platelets. Thus, there is a constant need for novel and innovative advancements in the market. Some of the areas of improvement include accuracy of the stents, enhancement in the work flow and procedure and reduction in error. Development of biodegradable polymer stents, bioresorbable stents, scaffolds and felicitation of minimally invasive procedures trends will drive the market for coronary stents during the forecast period.

Among all coronary stents types, both bare metals and drug eluting stent (DES) are extensively adopted in by patients and preferred by healthcare practitioners. Currently, drug eluting stents held the largest share in the global coronary stents market as it is considered as the gold standard treatment and will continue to exhibit strong growth during the forecast period. Drug eluting stents hold 80% of the market and is promoted by many healthcare professionals due to efficacy and benefits over other procedures. Moreover, with technological progress these stents have improved and reflected additional reduction in stent thrombosis. Using DES in stenting offers improved outcomes for patients with CAD treated with percutaneous coronary intervention (PCI). Bio-absorbable stents is projected to grow at a exponential rate during the forecast period. Bio-absorbable or Bioresorbable stents were introduced as an alternation owing to growing concerns of presence of stents for lifetime or until surgically eliminated. New product approvals and its benefits will surge the demand for these stents in global coronary stents market.

In terms of application, the global coronary stents market is segmented into angina and myocardial infarction. Angina held the largest share in this segment. Approximately, 80% of the total sales of coronary stents is generated by its application in angina. This application segment is expected to remain dominant throughout the forecast period owing to constantly rising target patient population across the world. Myocardial infarction accounted for the lower market share owing to smaller adoption of the device in this application. Lower adoption of this device would result in smaller revenue share throughout the forecast period.

The market research study on "Coronary Stents Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2025”, offers a detailed insights on the global coronary stents market entailing insights on its different market segments. Market dynamics with drivers, restraints and opportunities with their impact are provided in the report. Information about porter's five forces analysis is also covered under the report scope. The report provides insights on global coronary stents market, its type, application, and major geographic regions. The report covers basic development policies and layouts of technology development processes. Secondly, the report covers global coronary stents market size and volume, and segment markets by type, application, and geography along with the information on companies operating in the market. The coronary stents market analysis is provided for major regional markets including North America, Europe, China, Southeast Asia, Japan, India and rest of world followed by major countries.

The coronary stents market has high demand in North America region in 2017 and is anticipated to dominate the market during forecasted period. As per stroke association, approximately 1 million Americans each year are affected by stokes. Solitarily in the U.S., the financial drain of stroke is valued at $34 billion annually, which includes the expenditure on health care services, prescriptions, and reduced output. The ASA has put up great effort to transform the existing healthcare systems and patients worldwide by collaborating with other countries, governments and international cardiac societies.. Countries in this region have classic healthcare system, well planned program for compensation, and rise in number of population held a significant share in coronary stent market, worldwide. The new development in bio-absorbable stents with latest trends in growing popularity has been observed in this region. Asia Pacific is the second largest region and fastest growing as compared to others. China is the largest Asia-Pacific market for coronary stents. China has the largest population, with stroke one of the leading cause for death and claiming 1.6 million lives annually. China experiences similar stroke risk factors as compared to Western nations. Furthermore, China has identified specific geographic areas where the impermanence associated with stroke is 50% high than other regions in the country. Furthermore, growing healthcare infrastructure and target population in the countries like India, Japan, and Indonesia will further drive the market. Growing medical tourism in the region will further generate demand for coronary stents in the region. In China and India, the coronary stents market is increasing due to economic developments and rebuild of government. For example, a inclusive tax system and Goods and Services Tax (GST) in India avoid the effect of cascading tax, which helps both consumers and manufacturers to save tax. The players profiled in the report include Abbott Vascular, Medtronic, Boston Scientific, B. Braun Melsungen AG, Biotronik SE & Co. KG, Terumo, Stentys SA, Becton Dickinson and Co., Cook Group, SMT and Micro Port among others. Companies are engaging into mergers & acquisition and strategic alliances with universities and academic institutes to develop innovative products and maintain competitive edge over other competitors.

Market Segmentation

Market By Type

  • Bare Metal Stents
  • Drug Eluting Stent
  • Bio-absorbable stent

Market By Application

  • Angina
  • Myocardial Infarction

Market By Geography

  • North America
  • Europe
  • China
  • Southeast Asia
  • Japan
  • India
  • Rest of World

Related Reports

Medical Nonwoven Disposables Market (By Product: Incontinence Hygiene Products, Surgical Non-woven Products; By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Platform) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

The global medical nonwoven disposables market is forecasted to grow at a CAGR of 6.6% over the forecast time frame and reach around US$ 26.1 billion by 2026. The report provides analysis of global medical non-woven disposables market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights Nonwovens are a unique category of textile product enginee

Plastic Surgery Instruments Market (By Type: Handheld Surgical Instruments, Electrosurgical Instruments; By Procedure: Face and Head Procedures, Breast Procedures, Body and Extremities Procedures, Reconstruction Surgeries) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global plastic surgery instruments market size is anticipated to reach around US$ 1.7 billion by 2026 and expected to grow at a CAGR of 8.5% from period 2019 to 2026. Plastic surgery involves the restoration, replacement, alteration and rehabilitation of body regions, such as the head, skin, musculoskeletal, breast and others. The two main kinds of plastic surgery are cosmetic and reconstructive. Cosmetic o

Upper Limb Prosthetics Market (By Component: Prosthetic Arm, Prosthetic Wrist, Prosthetic Shoulder, Prosthetic Elbow, Terminal Devices; By Product: Body Powered Prosthetic Devices, Passive Prosthetic Devices, Hybrid Prosthetic Devices, Myoelectric Prosthetic Devices; By Cause: Vascular Disease and Diabetes, Trauma, Cancer; By End Use: Ambulatory Surgical Centers, Hospitals, Prosthetic Clinics) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global upper limb prosthetics market size is expected to worth US$ 1.9 billion by 2026 and poised to grow at a CAGR around 10.5 % from period 2019 to 2026. The prothetics of the upper limbs have gone a long way from their ancient origins to advanced and advanced protheses of today's moments.  Today, the highest prothesis implants consist of aluminum, plastics and sophisticated composite components. The

MRI-Guided Neurosurgical Ablation Market (By Product: Accessories, MRI-guided Laser Ablation Systems, MRI-guided Focused Ultrasound Systems, MRI-guided Radiofrequency Ablation Systems; By End-use: Clinics, Ambulatory Surgical Centers, Hospitals) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global MRI-guided neurosurgical ablation market is forecasted to grow at a CAGR around 4.3% from period 2019 to 2026 and reach around US$ 5.4 billion by 2026. The report provides analysis of global MRI-guided Neurosurgical Ablation market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights An gr

Self-Monitoring Blood Glucose Devices Market (By Product: Continuous Glucose Monitors, Lancets, Self-monitoring Blood Glucose Meters, Testing Strips; By Application: Type 2 Diabetes, Type 1 Diabetes, Gestational Diabetes; By End-Use: Home Usage, Hospitals, Diagnostic Clinics & Centers) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction According to Acumen Research and Consulting, The global self-monitoring blood glucose devices market size is expected to reach US$ 19 billion by 2026 and market is growing at a CAGR of 5 % from 2019 to 2026. Diabetes is a clinical disorder in which the blood glucose level rises owing to the pancreas ' incapacity to generate insulin. Monitoring glucose is one of the most important measures in the leadership of diabetes

Ovarian Cancer Diagnostics Market (By Diagnosis Type: Imaging, Biopsy, Blood Test, Others; By Cancer Type: Germ Cell Tumor, Stromal Cell Tumor, Epithelial Tumor, Others; By End-Use: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes, Others) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction  According to Acumen Research and Consulting, the global ovarian cancer diagnostics market is forecasted to grow at striking CAGR around 5.9 % over the forecast time frame and reach around US$ 1.8 billion by 2026. One of the most prevalent kinds of cancer in females is ovarian cancer. It is a cancer which begins in the ovaries. Ovary is a woman reproductive organ that contains eggs or ova. There are two ovaries i

Cart Summary